1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow SAR: new trials by email Literature Review of SAR trials Research Report on SAR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas CCT301-38 - SAR | Phase 1 | Terminated | Shanghai PerHum Therapeutics Co., Ltd. | 9 | 2021-12-30 | 2024-10-28 |
| Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients allogeneic mesenchymal stem cell, Placebo - Covid19, Corona Virus Infection | Phase 1 | Completed | Ina-Respond | 9 | 2020-11-14 | 2021-01-27 |
COVID-19 (1) · Communicable Diseases (1) · Coronavirus Infections (1) · Sarcoma (1)
Coronaviridae Infections (1) · Disease Attributes (1) · Infections (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1) · Nidovirales Infections (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Ina-Respond (1) · Shanghai PerHum Therapeutics Co., Ltd. (1)
China (1) · Indonesia (1)